Study on the Medical Education Capability of the EyeTeacher Artificial Intelligence Platform (EyeTeacher)

December 29, 2024 updated by: Tien Yin Wong, Tsinghua University

With the rise of generative artificial intelligence and large language models, medical education is undergoing a significant transformation. Numerous studies have highlighted the limitations of traditional educational knowledge acquisition and the potential impact of artificial intelligence on medical education, resident training, and continuing education for clinical practitioners. However, there is a lack of real-world experiments on the effectiveness of AI-integrated education.

Artificial intelligence can provide extensive educational resources and tools that are not limited by geographical location or language, thereby lowering the barrier to accessing high-quality medical education and promoting educational equity. Nevertheless, the performance of AI models trained by different medical institutions or healthcare systems may vary.

To offer a more universal, accessible, high-quality, and interconnected educational journey. We have developed a virtual ophthalmology teacher, which developed based on foundational model and large language models. This model, named EyeTeacher provide comprehensive theoretical knowledge and clinical skills enhancement for untrained medical students. To verify the effectiveness of our EyeTeacher across different national ophthalmology education systems and languages, we plan to implement a randomized controlled trial. This trial will assess the clinical capabilities of all participants and explore the advantages and disadvantages of the system compared to traditional teaching methods.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

252

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Victoria
      • Melbourne, Victoria, Australia, 3010
    • Beijing
      • Beijing, Beijing, China, 430022
        • Peking Union Medical College Hospital
        • Contact:
    • Greater Accra Region
      • Accra, Greater Accra Region, Ghana, P.O. Box LG 586
        • University of Ghana
        • Contact:
          • Kwesi Amissah-Arthur
          • Phone Number: +233-(0)302-213820
          • Email: pad@ug.edu.gh
    • Tamil Nadu
      • Chennai, Tamil Nadu, India, 600 006
        • Sankara Nethralaya
        • Contact:
      • Kuala Lumpur, Malaysia, 50603
        • University of Malaya
        • Contact:
      • Singapore, Singapore, 169857
      • London, United Kingdom, EC1V 2PD
        • Moorfields Eye Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Clinical medical students who have not taken ophthalmology courses
  • Age 21-40
  • Gender not restricted
  • Sign the informed consent form

Exclusion Criteria:

  • Refusal of the research protocol.
  • Participants unwilling or unable to understand and complete the questionnaire.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group
Attend EyeTeacher lecture before taking the regular ophthalmology lecture in medical school.
Participants randomized to the intervention group will receive access to the EyeTeacher system, along with their username, password, and a user manual, one week before the start of the course. They will follow instructions on the website and complete a quiz before and after each course. After completing the EyeTeacher curriculum, they will take the first examination (Examination 1) and complete a set of questionnaires. A classroom will be provided for study purposes, but no restrictions will be imposed on the study location. Following the EyeTeacher section, participants will attend the ophthalmology course in the regular training program, with support from the EyeTeacher system. They will be evaluated according to the ophthalmology posting's evaluation criteria (Examination 2).
No Intervention: Control group
Attend regular ophthalmology lectures in medical school.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grade of ophthalmology examination
Time Frame: 1 day after complete lectures

Title: Ophthalmology Theoretical Examination. The examination includes 40 multiple-choice questions and two essay questions related to ophthalmology knowledge, to be completed within one hour without the use of reference materials. The exam will be graded by experts based on a standardized answer key. The score ranges from 0 to 100, with a higher score indicating a deeper understanding of the ophthalmology knowledge.

Students in both the interventional group and the control group will complete the exam within the specified time on the EyeTeacher system. The data will be collected in the system's backend.

1 day after complete lectures

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of studying ophthalmology
Time Frame: 1 day after complete lectures

The study time spent using each teaching module in the interventional group is tracked by the EyeTeacher system website, while the study time for the control group and the out-of-system study time for the interventional group are collected through a questionnaire.

Questionnaire title: Time of Study in Ophthalmology The questionnaire consists of fill-in-the-blank questions, with time measured in minutes. The content includes: class time, exercise time, discussion time, and reading reference material time. The questionnaires for both the interventional and control groups are completed on the EyeTeacher system, and the data is collected through the backend.

1 day after complete lectures
Feedback of teaching from students
Time Frame: 1 day after complete lectures

Questionnaire title: Feedback of Study in Ophthalmology:

The Likert scale is used for scoring. The topics include students' evaluations of course design, teacher guidance, empathy, as well as students' self-assessment and evaluation of their interest in ophthalmology.

The questionnaires for both the interventional and control groups are completed on the EyeTeacher system, and the data is collected through the backend.

1 day after complete lectures

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 5, 2025

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

December 5, 2024

First Submitted That Met QC Criteria

December 29, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 29, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • THU01-20240100

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical Education

Subscribe